Cargando…
P331: THE ONCOGENIC TRANSCRIPTION FACTOR TCF3::HLF MARKS A DISTINCT ENHANCER-PROMOTER INTERACTION NETWORK IN T(17;19) POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Autores principales: | Priebe, Valdemar, Drakul, Aneta, Zeyen, Stefan, Bornhauser, Beat, Santoro, Raffaella, Bourquin, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428401/ http://dx.doi.org/10.1097/01.HS9.0000968236.88138.e3 |
Ejemplares similares
-
TCF3::HLF acute lymphoblastic leukemia: still challenging to cure thirty years later
por: Tasian, Sarah K.
Publicado: (2023) -
Aurora A kinase as a target for therapy in TCF3-HLF rearranged acute lymphoblastic leukemia
por: Leonard, Jessica, et al.
Publicado: (2021) -
Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
por: Fischer, Ute, et al.
Publicado: (2015) -
TCF3-HLF-Positive Acute Lymphoblastic Leukemia Resembling Burkitt Leukemia: Cell Morphologic and Immunophenotypic Findings
por: Li, Meng-Ju, et al.
Publicado: (2022) -
Resistance of t(17;19)‐acute lymphoblastic leukemia cell lines to multiagents in induction therapy
por: Watanabe, Atsushi, et al.
Publicado: (2019)